ArticleBiostatistics (Oxford, England)2025
While-alive regression analysis of composite survival endpoints.
Article in Biostatistics (Oxford, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Doubly Robust Estimators of the Restricted Mean Time in Favor Estimands in Individual- and Cluster-Randomized Trials.Statistics in medicine · 2026Article
- CRT-Estimands Framework: consensus based extension of the ICH E9(R1) addendum for cluster randomised trials.BMJ (Clinical research ed.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Composite endpoints are frequently used in clinical trials to enhance the event rate and improve the statistical power. In the presence of a terminal event, the while-alive cumulative frequency measure offers a useful alternative to define composite survival outcomes, by relating the average event rate to the survival time. Although non-parametric methods have been proposed for two-sample comparisons, limited attention has been given to regression methods that directly address time-varying association effects in while-alive measures. We address this gap by developing a regression framework for exposure-weighted while-alive measures for composite survival outcomes that include a terminal component event. Our regression approach uses splines to model time-varying association between covariates and a generalized while-alive loss rate of all component events, and can be applied to both independent and clustered data. We derive the asymptotic properties of the regression estimator under both independent data and cluster-correlated data settings, and study the operating characteristics of our methods through simulations. Finally, we apply our regression method to analyze data two randomized clinical trials. The proposed methods are implemented in the WAreg R package.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.